MS HR43

Recognizes the need for cardiovascular risk reduction through screening for and treatment of metabolic syndrome in Mississippi.

Identifies metabolic syndrome components including obesity, type 2 diabetes, hypertension, and dyslipidemia as major health threats, with only 20% of U.S. adults meeting optimal metabolic metrics.

Cites Mississippi's current obesity rate over 40% projected to reach 66.7% by 2030, generating $925 million in obesity-related healthcare costs in 2008 and $2.74 billion in diabetes-related costs in 2012.

Supports removing barriers to treatment including lack of insurance coverage for obesity medications, limited access to care for underserved populations, and insufficient provider training.

Supports following current clinical practice guidelines for aggressive cardiovascular risk reduction and notes that a 5-7% weight loss can delay or prevent type 2 diabetes.